What's Going On With Jaguar Health Stock?
What's Going On With Jaguar Health Stock?
Jaguar Health, Inc. (NASDAQ:JAGX) shares are trading lower Thursday, and the stock is down more than 65% over the past five days.
捷豹健康公司（納斯達克股票代碼：JAGX）股價週四走低，該股在過去五天中下跌了65％以上。
The Details:
細節：
Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order to support the company's compliance with Nasdaq listing requirements.
捷豹健康股價下跌，此前該股週四以1比60的匯率進行了反向拆分，以支持該公司遵守納斯達克的上市要求。
Last week, Jaguar reported worse-than-expected first-quarter results with losses of 6 cents per share, compared to the losses of 3 cents per share analyst estimate. Quarterly sales also came in below the consensus estimate at $2.351 million.
上週，捷豹公佈的第一季度業績低於預期，每股虧損6美分，而分析師估計的每股虧損爲3美分。季度銷售額也低於市場普遍預期的235.1萬美元。
Jaguar Health is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic diarrhea.
Jaguar Health是一家處於商業階段的製藥公司，專注於爲患有胃腸道不適，特別是慢性腹瀉的人和動物開發新型、植物性、非阿片類和可持續衍生的處方藥。
Related News: Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
相關新聞： 專家預測 COVID-19 病例將增加：疫苗庫存攀升
Should I Sell My JAGX Stock?
我應該賣出我的 JAGX 股票嗎？
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
是賣出還是持有股票在很大程度上取決於投資者的策略和風險承受能力。波段交易者可能會出售表現跑贏大盤的股票以鎖定資本收益，而長期投資者可能會在股價進一步增長的預期下渡過難關。
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
同樣，願意最大限度地減少損失的交易者可能會賣出下跌一定百分比的股票，而長期投資者則可能將其視爲以折扣價購買更多股票的機會。
Shares of Jaguar Health have lost 85.09% year to date. This compares to the average annual return of -92.74%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.
迄今爲止，捷豹健康的股價已下跌85.09％。相比之下，平均年回報率爲-92.74％，這意味着該股的表現超過了歷史平均水平。投資者可以將股票的走勢與其歷史表現進行比較，以評估這是正常走勢還是潛在的交易機會。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Jaguar Health stock currently has an RSI of 10.93, indicating oversold conditions.
投資者也可以考慮市場動態。相對強弱指數可用於表明股票是超買還是超賣。捷豹健康股票目前的相對強弱指數爲10.93，這表明存在超賣情況。
For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.
如需分析工具、圖表數據和獲取獨家股票新聞，請查看 Benzinga PRO。免費試用。
JAGX Price Action: According to Benzinga Pro, Jaguar Health shares are down 20.5% at $6.11 at the time of publication Thursday.
JAGX價格走勢：根據Benzinga Pro的數據，捷豹健康股價在週四發佈時下跌20.5％，至6.11美元。
Image: Clker-Free-Vector-Images from Pixabay
圖片：來自 Pixabay 的 Clker-Free-Vector-Images
譯文內容由第三人軟體翻譯。